Tag Archives | THC

High on Health: CBD in the Food Supply

weed_3Just in time for 4/20: Reality Sandwich’s Alan Badiner writes about the presence of naturally-occurring endocannabinoids in the food supply:

Aside from the cannabinoids produced by the body and those found in cannabis, there are numerous substances that interact with the endocannabinoid system, such as cacao, black pepper, echinacea, tumeric and even carrots. But it is the Cannabis plant that produces the most powerful cannabinoids mimicing most closely those produced by the body. No downsides, no side-effects, no drug interaction issues, and so far, no giving up your hard earned funds to big pharma.

Make no mistake, I’m not referring to THC, of which Americans smoke more of per person than any other people on Earth, but rather the “other,” non-psychoactive cannabinoid called Cannabidiol (CBD), a prominent molecular component of the cannabis plant.  While CBD does not bind to either the CB1 or CB2 cannabinoid receptors directly, it does stimulate endogenous cannabinoid activity by suppressing an enzyme that breaks down anandamide.

Read the rest

Continue Reading

Will Big Pharma Take Over The American Market For Medical Marijuana?

MedMarjIf the hundreds of uses for cannabis doesn’t plead the case for its legalization, the money made from its medical industry just might do it. The Washington Independent reports:

The American Independent has previously reported on the growing corporatization of the incipient medical marijuana industry at a time when medical marijuana dispensaries scrabble to hold on to their businesses in the face of a multi-pronged federal crackdown. But there are signs afoot that it just may become ever more corporate if a Big Pharma push to get the U.S. Food and Drug Administration to recognize a cannabis-derived drug is successful.

Last week, British prescription drug manufacturer GW Pharmaceuticals announced a licensing agreement with drug giant Novartis, maker of Ritalin and Excedrin, to begin selling GW’s drug Sativex in markets across Asia, Africa, Oceania and the Middle East. The medication is already available in Britain, where it’s produced and marketed by Bayer, and in Canada and Spain.

Read the rest

Continue Reading